Article
Active Efflux System for Cisplatin in Cisplatin‐resistant Human KB Cells
1 Apr 1994
Abstract excerpt
Mutants, KCP-4 and PC-5, resistant to an anticancer agent, cisplatin, were selected in multiple steps from human epidermoid KB carcinoma cells and human prostate PC-3 carcinoma cells, respectively. KCP-4 and PC-5 were 63 and 10 fold more resistant to cisplatin than the parental cells, respectively. KCP-4 cells exhibited increased resistance to cisplatin analogues and were also slightly cross-resistant to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
